Literature DB >> 3470163

Changing metastatic patterns of a transplantable rat osteosarcoma.

F Wingen, E Weber.   

Abstract

Metastatic behavior patterns in 303 untreated Sprague-Dawley rats bearing a transplantable cerium-144-induced osteosarcoma is described. The influence of survival time, sex, age of donor and recipient animals at time of transplantation, on the development of metastasis in lungs, kidneys, lymph nodes and liver was investigated. Nearly all (98.7 per cent) rats bearing osteosarcomas in the knee region developed primary hematogeneous lung metastases and 10.6 per cent of these developed secondary metastasis in the kidneys. A further primary, lymphogenous metastatic spread occurred in 15.5 per cent of the animals. Ninety-two per cent of the rats died because of lung metastases, but animals with long survival times developed significantly more extrapulmonary metastases than animals with a shorter survival time. This is an agreement with the observed change in metastatic patterns in osteosarcoma patients with prolonged survival after adjuvant chemotherapy. Moreover, the age of the donor-tumors and the recipient animals influenced survival time and consequently metastatic patterns. It was therefore possible to keep available several groups of osteosarcoma-bearing animals with different expectations of survival time. The results of transplantation of the same tumor by the intraperitoneal and the intravenous route are also presented.

Entities:  

Mesh:

Year:  1987        PMID: 3470163     DOI: 10.1007/BF00116622

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  18 in total

1.  [Experimental studies on metastasis formation of tumors in rats].

Authors:  D SCHMAHL; T RIESEBERG
Journal:  Z Krebsforsch       Date:  1958

2.  [Beryllium induced bone sarcomas (author's transl)].

Authors:  D Komitowski
Journal:  Verh Dtsch Ges Pathol       Date:  1974

3.  Cell-cycle specificity and therapeutic effectiveness of cytostatic agents.

Authors:  L M Van Putten; P Lelieveld; L K Kram-Idsenga
Journal:  Cancer Chemother Rep       Date:  1972-12

4.  Experimental bone tumors as models of human bone tumors.

Authors:  D Komitowski
Journal:  Pathol Res Pract       Date:  1979-12       Impact factor: 3.250

5.  Osteogenic sarcoma in the American black.

Authors:  A G Huvos; A Butler; S S Bretsky
Journal:  Cancer       Date:  1983-11-15       Impact factor: 6.860

6.  Synthesis, antitumor activity, distribution and toxicity of 4-[4-[bis(2-chloroethyl)amino]phenyl]-1-hydroxybutane-1 1-bisphosphonic acid (BAD), a new lost derivative with increased accumulation in rat osteosarcoma.

Authors:  F Wingen; H Sterz; H Blum; H Möller; W Pittermann; B L Pool; H J Sinn; H Spring; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  Distribution of 3-amino-1-hydroxypropane-1,1-diphosphonic acid in rats and effects on rat osteosarcoma.

Authors:  F Wingen; D Schmähl
Journal:  Arzneimittelforschung       Date:  1985

8.  Changing indications for bone scintigraphy in patients with osteosarcoma.

Authors:  H Goldstein; B J McNeil; E Zufall; N Jaffe; S Treves
Journal:  Radiology       Date:  1980-04       Impact factor: 11.105

9.  Changing metastatic patterns of osteosarcoma.

Authors:  A E Giuliano; S Feig; F R Eilber
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

10.  Statistical methods for censored survival data.

Authors:  N Breslow
Journal:  Environ Health Perspect       Date:  1979-10       Impact factor: 9.031

View more
  3 in total

1.  Metastatic osteosarcoma to the liver and the kidney: a case report and review of the literature.

Authors:  Wen-Xi Yu; Yang Yao
Journal:  BMJ Case Rep       Date:  2009-02-26

2.  In vivo and in vitro investigations on biological effects of aromatic bis-(2-chloroethyl)amino-bisphosphonic acids, new agents proposed for chemotherapy of bone tumors: cytostatic activity in rat osteosarcoma; toxicity and genotoxicity in liver and bone marrow; mutagenicity in S. typhimurium.

Authors:  B L Pool; M Berger; J R Schlehofer; F Wingen
Journal:  Invest New Drugs       Date:  1988-06       Impact factor: 3.850

3.  Antimetastatic effects of razoxane in a rat osteosarcoma model.

Authors:  F Wingen; H Spring; D Schmähl
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.